6847.TWO Puriblood Medical Co., Ltd.

Healthcare Diagnostics & Research Taiwan OTC Exchange
71.10 TWD
Close of Nov 6, 2026
47.75 93.70
Market cap
TWD 1.23B
P/E
-
P/B
11.20x
ROE
-27.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6847.TWO undervalued?

Graham number

The Graham number of Puriblood Medical Co., Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Puriblood Medical Co., Ltd. fundamental analysis

No fundamental analysis for Puriblood Medical Co., Ltd. yet.

Puriblood Medical Co., Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Puriblood Medical Co., Ltd.

Puriblood Medical Co., Ltd. engages in the research and development of blood purification-related medical devices in Taiwan and internationally. The company offers leukoreduction, cell separation, and P-Tex, an anti-fouling technology, which is composed by bio-inspired molecular formula. It is also involved in animal blood transfusion. Puriblood Medical Co., Ltd. was incorporated in 2015 and is based in Hsinchu City, Taiwan.

Full company profile